Occupancy is saving the quarter—but the ADR alarm should not be ignored
Reported profit jumped 29.7%, but the lift came from falling finance costs, not from stronger hotel operations. Same-store revenue grew 9.1%, within guidance, but only because occupancy gains (+510 bps) masked stalled pricing power (ADR +2.6%).
9.1%
vs. 9–11% guided
₹24.9 Cr
+29.7% YoY
+12.1%
ex GST impact and one-times
+2.6–2.7%
Softest in 2 quarters
Samhi Hotels delivered its ninth consecutive year of profitable growth, and on the surface the quarter looks clean: revenue is up 12.1%, profit is up 29.7%, same-store growth hit the 9–11% guidance band. But the composition tells a story the headline masks. Occupancy rose 510 basis points to 79.3%, domestic resilience held at 82% of room nights, yet average daily rates grew only 2.6–2.7%—the softest growth in two quarters. The 29.7% PAT jump came not from operating strength, but from a 25.5% drop in finance costs as the company deleveraged. Strip that out, and the organic operational quarter is respectable, not exceptional.
What the numbers actually say
Revenue of ₹305.2 Cr posted 12.1% YoY growth, but that includes a ₹9.3 Cr one-time other income item in Q1 FY26 (a GIC revaluation gain). On a comparable basis—same hotels, same accounting—the growth was 10.8%, still solid. EBITDA reported down 4% YoY, the victim of a ₹9.2 Cr negative swing from the GST regime change (moving from 12% with input tax credit to 5% without, on midscale properties priced below ₹7,500 per night). That regime shift hit only Q1; it will continue through Q2, then ease from Q3 onward as prior-year comparisons normalize. Adjusted for this one-time, comparable EBITDA grew 12.1%—a healthy 120 basis points of operational leverage on a 10.8% top-line gain.
Where the PAT lift came from
The 29.7% profit growth is real, but its source matters. Finance costs fell 25.5% to ₹37.7 Cr as the company reduced net debt and locked in an effective rate of 7.8% (300 basis points below the IPO rate). This deleveraging is genuine progress—it reflects disciplined capex and cash generation—but it is a balance-sheet story, not an operating-leverage story. On a comparable operating basis (stripping the GST impact), EBITDA grew 12.1%. Pre-tax profit (PBT) rose 26.4%, closely tracking the EBITDA growth plus the finance-cost benefit. Net profit of ₹24.9 Cr thus delivers +29.7% YoY, hitting the upper range of what the operational quarter would have supported.
The rate growth alarm
The single biggest tell in this quarter is that ADR growth has stalled. Across the portfolio, average daily rates rose only 2.6–2.7%—the softest in two quarters (Q4 FY26 was flat). This is not a revenue-management choice; it is a market reality driven by the West Asia geopolitical crisis, which hollowed out international business travel into India. International arrivals, which typically command a 10–20% premium on rates and 15–20% on food and beverage, contracted to 18% of room nights (from 22% prior year). The portfolio responded by filling rooms with domestic travelers—who are more price-sensitive—and achieved a 510 basis point occupancy gain. But this is a near-term cushion, not a sustainable growth model. F&B revenue, which typically comes disproportionately from international guests, grew only 3.7% despite room revenue growing 14%. Management flagged that international premium will recover as geopolitical tensions ease (July data, per the call, showed rate growth re-accelerating), but one month does not a trend make.
What changed on this call
Net debt-to-EBITDA target extended from 12–18 months to FY28
ADR growth decelerated: double-digit (historical) → 2.6–2.7% (Q1)
RARE leisure platform capital commitment grew to ₹60 Cr (₹47 Cr + Itmenaan Estate ₹12 Cr)
On leverage, the prior FY26 call guided for 2.5x net debt-to-EBITDA within 12–18 months. Today, at 3.2x trailing (2.4x on an operating-assets basis), management revised the target to FY28—more honest, though a pushback from the prior implied timeline. The company maintains that stable net debt plus EBITDA growth will get there, and the math works if EBITDA reaches ~₹550 Cr annualized by FY28 (currently ~₹400 Cr annualized, a ~37% growth requirement). That is achievable if same-store growth holds 9–11% and the upscale mix shift (from 40% today to 60% by FY30) materializes, but it assumes H2 rate recovery and project execution.
The bull and bear case
The bull-bear ledger
Occupancy 79.3% (+510 bps) demonstrates portfolio strength
Domestic resilience at 82% of room nights cushions rate softness
Finance costs down 25.5%; effective rate 7.8% below IPO
Same-store revenue growth 9.1% vs. 9–11% guidance—delivered as promised
1,660-room pipeline and upscale mix shift (to 60% by FY30) structurally accretive
ADR growth 2.6–2.7% is the softest in two quarters; rate recovery uncertain
International mix down to 18%; premium 10–20% on rates, 15–20% F&B lost
F&B +3.7% vs. room +14%; blended yield compression evident
GST headwind ₹9.2 Cr Q1, continues Q2, eases Q3 onward
Net debt-to-EBITDA 3.2x; FY28 target requires ~37% EBITDA growth
RARE economics unproven; ₹60 Cr invested, targeting ₹35–40 Cr EBITDA in 2 years
Navi Mumbai groundbreaking slipped to Apr 2027; regulatory approval risk
Risks, ranked by severity to a holder
International travel disruption persists
HighWest Asia crisis unresolved; if business travel stays depressed, ADR growth stays capped at 2–3%. F&B upside muted. Rate recovery deferred to late FY28 or FY29.
GST margin headwind in H1
HighMidscale portfolio (23% of revenue) hit ₹9.2 Cr in Q1; continues Q2, eases Q3. Near-term EBITDA margin pressure despite operational leverage upside.
Leverage at 3.2x; FY28 target credible but tight
Medium-HighRequires ~37% annualized EBITDA growth. Achievable if same-store growth holds 9–11% and upscale mix shift executes, but zero margin for error on FY28 capex or macro shock.
Project execution and regulatory delays
HighNavi Mumbai (largest, dual-branded, ~550 rooms) groundbreaking slipped to Apr 2027 (3–4 yr delivery). Regulatory approval risk; statutory approvals pending. W Hyderabad on track for S2 FY28, but execution risk remains.
RARE economics early-stage and unproven
Medium₹60 Cr invested (₹47 Cr platform, ₹12 Cr Itmenaan), targeting ₹35–40 Cr EBITDA in 2 years. Only 40/75 hotels on Marriott (53%); model depends on platform growth and hoteliers' compliance. Commission-based revenue scales with bookings, not guaranteed.
Equity dilution overhang (₹750 Cr enabling resolution)
MediumAnnual enabling resolution creates uncertainty on dilution timing and magnitude. Management frames as optionality, but precedent in capital-intensive sectors suggests large raises possible. No detail on equity/debt mix.
How the street is positioned
The stock's price action tells its own story. At ₹163.37, it trades 24.82% below its all-time high of ₹217.3, below its 20-day, 50-day, and 200-day moving averages (at ₹172.34, ₹171.83, and ₹170.25 respectively). RSI of 34.1 signals neither oversold nor overbought—the market has simply repriced the stock as a steady-growth story, not a re-rating story. The post-result price action was unambiguous: the stock fell 5.47% on day 1 of the result announcement, faded slightly to −2.99% by day 3, then slumped to −6.54% by day 5. That move did not bounce back. Foreign institutional investors hold 44.62% of the stock (up 33 basis points QoQ) and domestic institutions 17.35% (up 96 basis points), suggesting no panic selling, but neither are they adding aggressively. The narrative has shifted from 'growth re-rating' to 'execution and de-risking'—a longer holding period, not a faster payoff.
What to watch next
1 · Q2 FY27 rate trajectory (early Oct 2026 result)
GST YoY comparison normalizes; international mix should show early recovery. ADR growth re-acceleration (back toward 5–7%?) is the bell-ringer for rate-recovery confidence. If ADR stays sub-3%, the thesis risks re-rating lower.
2 · W Hyderabad opening and margin accretion (targeted S2 FY28)
First upscale opening post-mix-shift strategy. If it opens and delivers 70%+ occupancy with ADR >₹10,000, the 60% upscale portfolio thesis gains credibility. If opening slips or margins disappoint, the FY28 leverage target becomes harder.
3 · Navi Mumbai groundbreaking and regulatory timeline (Apr 2027 targeted)
Flagship capital-intensive project. If groundbreaking holds and statutory approvals progress (first set expected in coming months), confidence in the 1,660-room pipeline execution rises. Any delay pushes 2,500-room portfolio aspirations to post-FY30.
Samhi Hotels delivered a steady quarter—same-store guidance hit, occupancy resilient, finance costs down. But the composition signals headwinds: ADR growth has stalled, international travel remains disrupted, and the GST margin hit continues through H1. The multi-year thesis (9–11% growth, 2.5x leverage by FY28, upscale mix shift to 60%) is intact, but the near-term proof points are deferred to H2 and FY28.
The stock at ₹163.37, down 24.82% from ATH, is not a screaming buy—it is a show-me story. Buyers need to see rate recovery (July one month is insufficient) and project execution (Navi Mumbai, W Hyderabad). The number to track from here is the comparable EBITDA run-rate and occupancy on a reported basis. If comparable EBITDA reaches ~₹400 Cr by year-end (sustaining 12%+ growth), and occupancy stays above 78%, the FY28 leverage target becomes credible. Until then, this is a Hold for existing holders and a bounce-trade opportunity for new ones, not a conviction long.
Informational and educational content only. Not investment advice.